유럽 ​​신경병성 통증 시장 – 2030년까지의 산업 동향 및 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Healthcare Europe Neuropathic Pain Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

유럽 ​​신경병성 통증 시장 – 2030년까지의 산업 동향 및 예측

  • Healthcare
  • Upcoming Report
  • Sep 2023
  • Europe
  • 350 Pages
  • 테이블 수: 220
  • 그림 수: 60
지금 구매 지금 구매

Europe Neuropathic Pain Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Diagram 예측 기간
 2023 –2030
Diagram 시장 규모(기준 연도)
 USD 1,123.93 million
Diagram 시장 규모(예측 연도)
 USD 2,371.40 million
Diagram 연평균 성장률
 %
Diagram주요 시장 플레이어
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
잠금 해제 요청

>유럽 ​​신경병성 통증 시장, 유형별(척수 자극(SCS) 장치, 외부 말초 신경 자극, 경피 전기 신경 자극(Tens) 장치), 제품 유형(충전식 및 비충전식), 시술(침습적 및 비침습적), 기술(경피 전기 신경 자극, 경두 자기 자극 및 호흡 전기 자극), 양식(고정식 및 휴대용), 구매 방식(일반 의약품 및 처방 기반 장치), 통증 유형(말초 신경병, 압박 신경병, 환지 신경병, 삼차 신경통, 포진 후 신경통(PHN), 외상 후 신경병, 발 통증, 꼬리뼈 통증), 적응증(척추 협착증, 화학 요법 유발 말초 신경병, 당뇨병 신경병, 기타), 최종 사용자 (병원, 진료소, 재택 의료, 외래 수술 센터 및 기타), 유통 채널(직접 입찰, 제3자 유통업체 및 기타) – 2030년까지의 산업 동향 및 예측.

 유럽 ​​신경병성 통증 시장

유럽 ​​신경병성 통증 시장 분석 및 규모

다양한 시장 참여자들이 첨단 제품을 만들기 위해 R&D 지출을 늘리면 유럽 신경병성 통증 시장이 성장할 것으로 예상됩니다. 제품 사용을 제한하는 의료 기기 와 관련된 제한은 유럽 신경병성 통증 시장 성장에 제약으로 작용할 것으로 예상됩니다. 많은 국가에서 고령화와 노인 인구 증가로 인한 신경병성 통증의 위험이 높아져 유럽 신경병성 통증 시장이 성장할 기회가 생길 것입니다. 의료 지출이 낮고 공급망이 붕괴되어 신흥국에서 전통적 치료법을 사용하는 것은 유럽 신경병성 통증 시장 성장에 도전이 될 것으로 예상됩니다.

Data Bridge Market Research는 2022년에 1,123.93백만 달러였던 유럽 신경병성 통증 시장이 2030년까지 2,371.40백만 달러에 도달할 것으로 예상하고, 2023년에서 2030년까지의 예측 기간 동안 9.1%의 CAGR을 보일 것으로 분석했습니다. "척수 자극(SCS) 장치" 세그먼트는 기술의 발전으로 인해 유럽 신경병성 통증 시장의 유형 세그먼트를 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

유럽 ​​신경병성 통증 시장 범위 및 세분화

보고서 메트릭

세부

예측 기간

2023년부터 2030년까지

기준 연도

2022

역사적 연도

2021 (2015-2020까지 사용자 정의 가능)

양적 단위

매출은 백만 달러, 볼륨은 단위, 가격은 달러로 표시됨

다루는 세그먼트

Type (Spinal Cord Stimulation (SCS) Devices, External Peripheral Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation (Tens) Devices), Product Type (Rechargeable and Non-Rechargeable), Procedure (Invasive and Non-Invasive), Technology (Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation and Respiratory Electrical Stimulation), Modality (Stationary and Portable), Mode of Purchase (Over-the-Counter Devices and Prescription-Based Devices), Pain Type (Peripheral Neuropathy, Entrapment Neuropathy, Phantom Limb Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Post Traumatic Neuropathy, Foot Pain, Coccydynia), Indication (Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Others), End User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centres and Others), Distribution Channel (Direct Tender, Third Party Distributor and Others)

Countries Covered

Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe

Market Players Covered

NEVRO CORP. (U.S.), Boston Scientific Corporation (U.S.), Abbott (U.S.), electroCore, Inc. (U.S.), Polar Medical (England) , B. Braun Melsungen AG (Germany), Omron Healthcare, Inc. (Japan), Cirtec (U.S.), Medtronic (Ireland), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Virpax Pharmaceuticals, Inc. (U.S.), Amgen Inc. (U.S.), Integer Holdings Corporation (U.S.) and AVNS (U.S.)

Market Opportunities
  • Growing Patient Awareness
  • Rising Healthcare Expenditure
  • Rising strategic initiatives by key market players

Market Definition

Neuropathic pain is caused by a lesion or disease of the somatosensory system including peripheral fibres (Aβ, Aδ and C fibres) and central neurons and affects 7–10% of the general population. Multiple causes of neuropathic pain have been described and its incidence is likely to increase owing to the aging global population, increased incidence of diabetes mellitus and improved survival from cancer after chemotherapy.

Europe Neuropathic Pain Market Dynamics

Drivers

  • Increasing Prevalence of Neuropathic Pain

As the aging population grows and chronic diseases such as diabetes and cancer become more prevalent, the number of people suffering from neuropathic pain is on the rise. This demographic trend drives the demand for neuropathic pain treatments and medications.

  • Advances in Medical Research

Ongoing research into the causes and mechanisms of neuropathic pain has led to the development of new treatment options and therapies. As our understanding of neuropathic pain improves, more effective treatments are being developed, creating opportunities for pharmaceutical and biotech companies.

  • Novel Drug Development

Pharmaceutical companies are investing in the development of new drugs specifically designed to target neuropathic pain. These drugs aim to provide better pain relief with fewer side effects, improving the quality of life for patients.

Opportunities

  • Growing Awareness among Patients

Increased awareness of neuropathic pain and its impact on patients’ lives has led to a greater demand for effective treatments. Patients are becoming more proactive in seeking appropriate care and therapies.

  • Rising of Healthcare Expenditure

As healthcare expenditure continues to increase globally, there is more funding available for research, development, and access to neuropathic pain treatments and therapies.

Restraints/Challenges

  • Limited Efficacy of Current Treatments

Many existing medications and therapies for neuropathic pain offer only partial relief and can have side effects. This limited efficacy can lead to patient dissatisfaction and the search for alternative treatments.

  • Side Effects and Safety Concerns

Some neuropathic pain medications, including opioids and certain antidepressants, can cause side effects such as drowsiness, dizziness, and addiction. Managing these side effects can be challenging for both patients and healthcare providers.

This Europe neuropathic pain market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe neuropathic pain market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In January 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN), a debilitating complication of diabetes
  •  In July 2022, Vertex Pharmaceuticals Incorporated announced positive Phase 2 results of VX-548 in Acute and Neuropathic Pain by U.S. Food and Drug Administration (FDA)

Europe Neuropathic Pain Market Scope

The Europe neuropathic pain Market is segmented on the basis of type, product type, procedure, technology, modality, mode of purchase, pain type, indication, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Spinal Cord Stimulation (SCS) Devices
  • External Peripheral Nerve Stimulation
  • Transcutaneous Electrical Nerve Stimulation (Tens) Devices

Product Type

  • Rechargeable
  • Non-Rechargeable

Procedure

  • Invasive
  • Non-Invasive

Technology

  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Respiratory Electrical Stimulation

Modality

  • Stationary
  • 가지고 다닐 수 있는

구매 방식

  • 일반 의약품
  • 처방 기반 장치

통증 유형

  • 말초신경병증
  • 신경 압박증
  • 환지신경병증
  • 삼차신경통
  • 대상포진 후 신경통(PHN)
  • 외상 후 신경병증
  • 발 통증
  • 꼬리뼈통증

표시

  • 척추관 협착증
  • 화학 요법으로 유발된 말초 신경병증
  • 당뇨병 신경병증
  • 기타

최종 사용자

유통 채널

  • 직접 입찰
  • 제3자 유통업체
  • 기타

유럽 ​​신경병성 통증 시장 지역 분석/통찰력

위에 언급된 대로 국가, 유형, 제품 유형, 시술, 기술, 양식, 구매 방식, 통증 유형, 적응증, 최종 사용자 및 유통 채널별로 유럽 신경병성 통증 시장을 분석하고 시장 규모에 대한 통찰력과 추세를 제공합니다.

유럽 ​​신경병성 통증 시장 보고서에서 다루는 국가는 독일, 프랑스, ​​영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키 및 기타 유럽 국가입니다.

독일은 강력한 의료 시설 기반, 시장 내 주요 기업의 강력한 입지, 이 지역에서 증가하는 연구 활동 등으로 인해 유럽 신경병성 통증 시장을 장악하고 있습니다.   

독일은 정부의 인식 제고 이니셔티브 확대, 의료 관광 증가, 지역 내 연구 활동 증가, 대규모 미개척 시장의 가용성, 대규모 인구 집단, 지역 내 양질의 의료 서비스에 대한 수요 증가로 인해 2023년부터 2030년까지 유럽 신경병성 통증 시장이 상당한 성장을 보일 것으로 예상됩니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

의료 인프라 성장 설치 기반 및 신기술 침투

유럽 ​​신경병성 통증 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 유럽 신경병성 통증 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 유럽 신경병성 통증 시장에 미치는 영향. 이 데이터는 2015-2020년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 유럽 신경병성 통증 시장 점유율 분석

유럽 ​​신경병성 통증 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 유럽 신경병성 통증 시장과 관련된 회사의 초점에만 관련이 있습니다.

유럽 ​​신경병성 통증 시장에서 활동하는 주요 기업은 다음과 같습니다.

  • 네브로 주식회사(미국)
  •  보스턴 사이언티픽 코퍼레이션(미국)
  •  애벗(미국)
  •  일렉트로코어 주식회사(미국)
  •  폴라 메디컬(영국)
  •  B. Braun Melsungen AG(독일)
  •  오므론 헬스케어 주식회사(일본)
  •  시르텍(미국)
  •  메드트로닉(아일랜드)
  • 파이저 주식회사(미국)
  •  노바티스 AG(스위스)
  •  Virpax Pharmaceuticals, Inc. (미국)
  •  암젠 주식회사(미국)
  • Integer Holdings Corporation (미국)
  •  AVNS(미국) 

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE Neuropathic pain MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET type of manufacturer COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. regulation
    1. REGULATORY GUIDELINES AS PER USFDA
    2. REGULATORY GUIDELINES AS PER EUROPEAN UNION
  6. market overview
    1. drivers
      1. Growing prevalence of chronic pain and neuropathic condition
      2. Increasing Cases Of Diabetic Neuropathy
      3. Increasing R&D Expenditure
      4. Advancement In New Neuromodulation Technology
      5. Penetration Of the New Market Players
    2. RESTRAINTS
      1. High cost of the medical devices
      2. Low awareness for neuropathic pain devices
      3. unfavorable government policies
      4. Limitation of Neuropathic medical Devices
    3. OPPORTUNITIES
      1. High Risk Of Neuropathic Pain With Ageing
      2. Government initiatives for neuropathic pain
      3. Appropriate Reimbursement policy for the medical devices
    4. CHALLENGES
      1. Dearth of skilled professionals
      2. Use of traditional therapy in emerging economies
  7. IMPACT OF COVID-19 ON THE EUROPE NEUROPATHIC PAIN MARKET
    1. OVERVIEW
    2. IMPACT ON PRICE
    3. IMPACT ON SUPPLY
    4. STRATEGIC DECISIONS BY MANUFACTURERS
    5. CONCLUSION-
  8. europe Neuropathic pain MARKET, BY Type
    1. overview
    2. SPINAL CORD STIMULATION (SCS) DEVICES
      1. Rechargeable Implantable Pulse Generator
      2. Radiofrequency Stimulator
      3. Conventional Implantable Pulse Generator/ IPG
    3. EXTERNAL PERIPHERAL NERVE STIMULATION
      1. Deep Brain Stimulators (DBS)
        1. Dual-Channel Deep Brain Stimulator
        2. Single-Channel Deep Brain Stimulator
      2. Transcranial Magnetic Stimulators (TMS)
      3. Vagus Nerve Stimulators (VNS)
      4. Sacral Nerve Stimulators (SNS)
    4. TRANSCUTANEOUS ELECTRIC NERVE STIMULATION (TENS) DEVICES
      1. Conventional Tens (Low-intensity, High-Frequency)
      2. Acupuncture-Like Tens (High-Intensity, Low-Frequency)
      3. Intense Tens (High-Intensity, High-Frequency)
  9. europe Neuropathic pain MARKET, BY product type
    1. overview
    2. rechargeable
    3. non- rechargeable
  10. europe Neuropathic pain MARKET, BY Procedure
    1. overview
    2. Non-Invasive
    3. invasive
  11. europe Neuropathic pain MARKET, BY technology
    1. overview
    2. TRANSCUTANEOUS ELECTRIC NERVE STIMULATION
    3. TRANSCRANIAL MAGNETIC STIMULATION
    4. Respiratory Electrical Stimulation
  12. europe Neuropathic pain MARKET, BY Modality
    1. overview
    2. portable
      1. Rechargeable
      2. Non- Rechargeable
    3. stationary
      1. Rechargeable
      2. Non- Rechargeable
  13. europe Neuropathic pain MARKET, BY Mode of Purchase
    1. overview
    2. Prescription-Based Devices
    3. Over-The-Counter Devices
  14. europe Neuropathic pain MARKET, BY Pain Type
    1. overview
    2. Peripheral Neuropathy
    3. Phantom Limb Pain
    4. Post Herpetic Neuralgia (PHN)
    5. Post Traumatic Neuropathy
    6. Entrapment Neuropathy
    7. Foot Pain
    8. Trigeminal Neuralgia
    9. Coccydynia
    10. others
  15. europe Neuropathic pain MARKET, BY indication
    1. overview
    2. Spinal Stenosis
      1. Spinal Cord Stimulation (SCS) Devices
      2. Transcutaneous Electrical Nerve Stimulation (TENS) devices
      3. External Peripheral Nerve Stimulation
    3. Diabetic Neuropathy
      1. Spinal Cord Stimulation (SCS) Devices
      2. Transcutaneous Electrical Nerve Stimulation (TENS) devices
      3. External Peripheral Nerve Stimulation
    4. Chemotherapy-Induced Peripheral Neuropathy
      1. Spinal Cord Stimulation (SCS) Devices
      2. Transcutaneous Electrical Nerve Stimulation (TENS) devices
      3. External Peripheral Nerve Stimulation
    5. others
  16. europe Neuropathic pain MARKET, BY end user
    1. overview
    2. Clinics
    3. Hospitals
      1. Acute Care Hospitals
      2. Long-Term Care Hospitals
      3. Nursing Facilities
      4. Rehabilitation Centers
    4. Home Healthcare
    5. Ambulatory Surgical Centers
    6. others
  17. europe Neuropathic pain MARKET, BY distribution channel
    1. overview
    2. Direct Tenders
    3. Third Party Distribution
    4. others
  18. Europe neuropathic Pain market by geography
    1. Overview
    2. EUROPE
      1. GERMANY
      2. france
      3. U.K.
      4. Italy
      5. Russia
      6. Spain
      7. Netherlands
      8. Turkey
      9. Switzerland
      10. Rest of Europe
  19. Europe Neuropathic Pain Market: COMPANY landscape
    1. company share analysis: europe
  20. swot analysis
  21. Company profile
    1. medtronic
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. boston scientific corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. ABBOTT
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. nervo corp.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. omron healthcare, INC.
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. Interger holdings corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. avns
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. b.braun melsungen AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. Cirtec
      1. 257
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. ELECTROCORE, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. Neurometrix, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. Polar medical
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. Spr therapeutics
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. Stimwave LLC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    15. sunmed
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  22. questionnaire
  23. related reports

표 목록

TABLE 1 Europe Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 2 Europe Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 3 Europe Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 4 Europe External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 5 Europe External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 6 Europe Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 7 Europe Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 8 Europe Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 9 Europe Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)

TABLE 10 Europe Rechargeable in Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)

TABLE 11 Europe Non-Rechargeable Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)

TABLE 12 Europe Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)

TABLE 13 Europe Non-Invasive Invasive in Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)

TABLE 14 Europe Invasive in Neuroendocrine Tumors Market, By Classification 2019-2027 (USD Million)

TABLE 15 Europe Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)

TABLE 16 Europe Transcutaneous Electrical Nerve Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)

TABLE 17 Europe Transcranial Magnetic Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)

TABLE 18 Europe Respiratory Electrical Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)

TABLE 19 Europe Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)

TABLE 20 Europe Portable Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)

TABLE 21 Europe Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)

TABLE 22 Europe Stationary Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)

TABLE 23 Europe Stationary Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)

TABLE 24 Europe Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)

TABLE 25 Europe Prescription-Based Devices Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)

TABLE 26 Europe Over-The-Counter Devices Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)

TABLE 27 Europe Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 28 Europe Peripheral Neuropathy Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 29 Europe Phantom Limb Pain Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 30 Europe Post Herpetic Neuralgia (PHN) Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 31 Europe Post Traumatic NeuropathyNeuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 32 Europe Entrapment Neuropathy Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 33 Europe Foot Pain Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 34 Europe Trigeminal Neuralgia Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 35 Europe Coccydynia Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 36 Europe Others Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 37 Europe Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 38 Europe Spinal Stenosis Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 39 Europe Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 40 Europe Diabetic Neuropathy Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 41 Europe Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 42 Europe Chemotherapy-Induced Peripheral Neuropathy Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 43 Europe Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 44 Europe Others Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 45 Europe Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 46 Europe Clinics Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 47 Europe Hospitals Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 48 Europe Hospitals in Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 49 Europe Home Healthcare Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 50 Europe Ambulatory Surgical Centers Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 51 Europe Others Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 52 Europe Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 53 Europe Direct Tenders Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 54 Europe Third Party Distribution Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 55 Europe Others Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 56 EUROPE neuropathic Pain MARKET, BY REGION , 2021-2028 (USD MILLION)

TABLE 57 Europe NEUROPATHIC PAIN MARKET, By Region, 2019-2028 (USD Million)

TABLE 58 EUROPE NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 59 EUROPE Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 60 EUROPE External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 61 EUROPE Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 62 EUROPE Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 63 EUROPE NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 64 EUROPE NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 65 EUROPE NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 66 EUROPE NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 67 EUROPE Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 68 EUROPE portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 69 EUROPE NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 70 EUROPE NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 71 EUROPE NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 72 EUROPE SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 73 EUROPE Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 74 EUROPE Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 75 EUROPE NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 76 EUROPE hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 77 EUROPE NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 78 GERMANY NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 79 GERMANY Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 80 GERMANY External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 81 germany Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 82 GERMANY Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 83 GERMANY NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 84 GERMANY NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 85 GERMANY NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 86 GERMANY NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 87 GERMANY Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 88 GERMANY portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 89 GERMANY NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 90 GERMANY NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 91 GERMANY NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 92 GERMANY SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 93 GERMANY Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 94 GERMANY Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 95 GERMANY NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 96 GERMANY hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 97 GERMANY NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 98 france NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 99 france Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 100 france External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 101 france Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 102 france Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 103 france NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 104 france NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 105 france NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 106 france NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 107 france Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 108 france portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 109 france NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 110 france NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 111 france NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 112 france SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 113 france Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 114 france Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 115 france NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 116 france hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 117 france NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 118 U.K. NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 119 U.K. Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 120 U.K. External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 121 U.K. Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 122 U.K. Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 123 U.K. NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 124 U.K. NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 125 U.K. NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 126 U.K. NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 127 U.K. Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 128 U.K. portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 129 U.K. NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 130 U.K. NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 131 U.K. NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 132 U.K. SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 133 U.K. Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 134 U.K. Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 135 U.K. NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 136 U.K. hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 137 U.K. NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 138 italy NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 139 italy Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 140 italy External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 141 italy Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 142 italy Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 143 italy NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 144 italy NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 145 italy NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 146 italy NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 147 italy Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 148 italy portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 149 italy NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 150 italy NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 151 italy NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 152 italy SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 153 italy Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 154 italy Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 155 italy NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 156 italy hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 157 italy NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 158 russia NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 159 russia Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 160 russia External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 161 russia Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 162 russia Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 163 russia NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 164 russia NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 165 russia NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 166 russia NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 167 russia Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 168 russia portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 169 russia NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 170 russia NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 171 russia NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 172 russia SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 173 russia Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 174 russia Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 175 russia NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 176 russia hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 177 russia NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 178 spain NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 179 spain Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 180 spain External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 181 spain Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 182 spain Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 183 spain NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 184 spain NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 185 spain NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 186 spain NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 187 spain Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 188 spain portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 189 spain NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 190 spain NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 191 spain NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 192 spain SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 193 spain Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 194 spain Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 195 russia NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 196 spain hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 197 spain NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 198 Netherlands NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 199 Netherlands Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 200 Netherlands External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 201 Netherlands Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 202 Netherlands Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 203 Netherlands NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 204 Netherlands NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 205 Netherlands NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 206 Netherlands NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 207 Netherlands Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 208 Netherlands portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 209 Netherlands NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 210 Netherlands NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 211 Netherlands NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 212 Netherlands SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 213 Netherlands Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 214 Netherlands Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 215 Netherlands NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 216 Netherlands hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 217 Netherlands NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 218 turkey NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 219 turkey Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 220 turkey External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 221 turkey Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 222 turkey Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 223 turkey NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 224 turkey NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 225 turkey NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 226 turkey NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 227 turkey Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 228 turkey portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 229 turkey NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 230 turkey NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 231 turkey NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 232 turkey SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 233 turkey Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 234 turkey Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 235 turkey NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 236 turkey hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 237 turkey NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 238 Switzerland NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 239 Switzerland Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 240 Switzerland External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 241 Switzerland Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 242 Switzerland Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 243 Switzerland NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 244 Switzerland NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 245 Switzerland NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 246 Switzerland NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 247 Switzerland Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 248 Switzerland portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 249 Switzerland NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 250 Switzerland NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 251 Switzerland NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 252 Switzerland SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 253 Switzerland Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 254 Switzerland Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 255 Switzerland NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 256 Switzerland hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 257 Switzerland NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 258 Rest of Europe NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

그림 목록

FIGURE 1 Europe NEUROPATHIC PAIN MARKET: SEGMENTATION

FIGURE 2 EUROPE NEUROPATHIC PAIN MARKET: DATA TRIANGULATION

FIGURE 3 europe Neuropathic pain Market: DROC ANALYSIS

FIGURE 4 Europe Neuropathic pain market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Neuropathic pain Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Neuropathic pain MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Neuropathic pain MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE NEUROPATHIC PAIN MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE NEUROPATHIC PAIN MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE Neuropathic pain MARKET: MARKET type COVERAGE GRID

FIGURE 11 Europe Neuropathic pain market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE EUROPE Neuropathic pain market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 GROWING PREVALENCE OF CHRONIC PAIN, NEUROPATHIC CONDITION, AND INCREASING CASES OF DIABETIC NEUROPATHY IS DRIVING THE EUROPE NEUROPATHIC PAIN MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 SPINAL CORD STIMULATION (SCS) DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE NEUROPATHIC PAIN MARKET IN 2021 & 2028

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE NEUROPATHIC PAIN MARKET

FIGURE 16 ESTIMATED CASES OF PERIPHERAL NEUROPATHY IN AMERICAN POPULATION

FIGURE 17 PREVALENCE OF NEUROPATHIC PAIN IN TYPE 1 AND TYPE 2 DIABETES

FIGURE 18 europe Neuropathic pain market: BY type, 2020

FIGURE 19 europe Neuropathic pain market: BY type, 2020-2028 (USD Million)

FIGURE 20 europe Neuropathic pain market: BY type, CAGR (2020-2028)

FIGURE 21 europe Neuropathic pain market: BY type, LIFELINE CURVE

FIGURE 22 europe Neuropathic pain market: BY product type, 2020

FIGURE 23 europe Neuropathic pain market: BY product type, 2020-2028 (USD Million)

FIGURE 24 europe Neuropathic pain market: BY product type, CAGR (2020-2028)

FIGURE 25 europe Neuropathic pain market: BY product type, LIFELINE CURVE

FIGURE 26 europe Neuropathic pain market: BY procedure, 2020

FIGURE 27 europe Neuropathic pain market: BY procedure, 2020-2028 (USD Million)

FIGURE 28 europe Neuropathic pain market: BY procedure, CAGR (2020-2028)

FIGURE 29 europe Neuropathic pain market: BY procedure, LIFELINE CURVE

FIGURE 30 europe Neuropathic pain market: BY technology, 2020

FIGURE 31 europe Neuropathic pain market: BY technology, 2020-2028 (USD Million)

FIGURE 32 europe Neuropathic pain market: BY technology, CAGR (2020-2028)

FIGURE 33 europe Neuropathic pain market: BY technology, LIFELINE CURVE

FIGURE 34 europe Neuropathic pain market: BY modality, 2020

FIGURE 35 europe Neuropathic pain market: BY modality, 2020-2028 (USD Million)

FIGURE 36 europe Neuropathic pain market: BY modality, CAGR (2020-2028)

FIGURE 37 europe Neuropathic pain market: BY modality, LIFELINE CURVE

FIGURE 38 europe Neuropathic pain market: BY mode of purchase, 2020

FIGURE 39 europe Neuropathic pain market: BY mode of purchase, 2020-2028 (USD Million)

FIGURE 40 europe Neuropathic pain market: BY mode of purchase, CAGR (2020-2028)

FIGURE 41 europe Neuropathic pain market: BY mode of purchase, LIFELINE CURVE

FIGURE 42 europe Neuropathic pain market: BY pain type, 2020

FIGURE 43 europe Neuropathic pain market: BY pain type, 2020-2028 (USD Million)

FIGURE 44 europe Neuropathic pain market: BY pain type, CAGR (2020-2028)

FIGURE 45 europe Neuropathic pain market: BY pain type, LIFELINE CURVE

FIGURE 46 europe Neuropathic pain market: BY indication, 2020

FIGURE 47 europe Neuropathic pain market: BY indication, 2020-2028 (USD Million)

FIGURE 48 europe Neuropathic pain market: BY indication, CAGR (2020-2028)

FIGURE 49 europe Neuropathic pain market: BY indication, LIFELINE CURVE

FIGURE 50 europe Neuropathic pain market: BY end user, 2020

FIGURE 51 europe Neuropathic pain market: BY end user, 2020-2028 (USD Million)

FIGURE 52 europe Neuropathic pain market: BY end user, CAGR (2020-2028)

FIGURE 53 europe Neuropathic pain market: BY end user, LIFELINE CURVE

FIGURE 54 europe Neuropathic pain market: BY distribution channel, 2020

FIGURE 55 europe Neuropathic pain market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 56 europe Neuropathic pain market: BY distribution channel, CAGR (2020-2028)

FIGURE 57 europe Neuropathic pain market: BY distribution channel, LIFELINE CURVE

FIGURE 58 EUROPE neuropathic Pain market: SNAPSHOT (2020)

FIGURE 59 EUROPE neuropathic Pain market: BY COUNTRY (2020)

FIGURE 60 EUROPE neuropathic Pain market: BY COUNTRY (2021 & 2028)

FIGURE 61 EUROPE neuropathic Pain market: BY COUNTRY (2020 & 2028)

FIGURE 62 EUROPE neuropathic Pain market: BY Product & services (2021-2028)

FIGURE 63 Europe Neuropathic Pain MARKET: SNAPSHOT (2020)

FIGURE 64 Europe Neuropathic Pain MARKET: BY COUNTRY (2020)

FIGURE 65 Europe Neuropathic Pain MARKET: BY COUNTRY (2021 & 2028)

FIGURE 66 Europe Neuropathic Pain MARKET: BY COUNTRY (2020 & 2028)

FIGURE 67 Europe Neuropathic Pain MARKET: BY product & Services (2021-2028)

FIGURE 68 Europe Neuropathic Pain market: company share 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The Europe Neuropathic Pain Market will be worth USD 2,371.40 million by 2030.
The Europe Neuropathic Pain Market growth rate is 9.1% during the forecast period.
Increasing Prevalence of Neuropathic Pain & Advances in Medical Research are the growth drivers of the Europe Neuropathic Pain Market.
The type, product type, procedure, technology, modality, mode of purchase, pain type, indication, end user and distribution channel are the factors on which the Europe Neuropathic Pain Market research is based.
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN), a debilitating complication of diabetes & Vertex Pharmaceuticals Incorporated announced positive Phase 2 results of VX-548 in Acute and Neuropathic Pain by U.S. Food and Drug Administration are the latest developments in the Europe Neuropathic Pain Market.

관련 페이지 탐색

Banner